HIGHLIGHTS
- who: COVID and colleagues from the Institut National de la Santé et de la Recherche Médicale (INSERM), France São Paulo State University, Brazil have published the paper: Bismuth subsalicylate as potential treatment for Covid-19 pneumonia: A case series report, in the Journal: (JOURNAL)
SUMMARY
Frontiersin.org 10.3389/fddsv.2022.962988 5 days prior to the reception of BiS, a positive response would have to be seen within 5 days of the last dose of BiS. Patients who had longer periods of high oxygen requirements prior to administration of BiS . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.